Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Drugs Market

Animal Drugs Market Size

  • Report ID: GMI4445
  • Published Date: Dec 2022
  • Report Format: PDF

Animal Drugs Market Size

Animal Drugs Market size crossed USD 35 billion in 2022 and is projected to expand at a 5.4% CAGR from 2023-2032.

 

Increasing cases of obesity in companion animals will affect animal drugs industry dynamics. Obesity is a major healthcare concern among pet parents and in animal husbandry as it induces a higher risk of osteoarthritis & diabetes mellitus, reduces the quality of life, and shortens life span.

 

Due to increasing incidences of animal obesity, the demand for animal drugs is anticipated to pick up pace in the near future. As per the Veterinary Centers of America (VCA) data, approximately 25% to 30% of the general dog population in the U.S. is obese, with 40%-45% of dogs within 5-11 years of age weighing more than the ideal body mass index (BMI).
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for animal drugs crossed USD 35 billion in 2022 and is projected to expand at a 5.4% CAGR from 2023-2032.

Livestock animals segment accounted for more than USD 22 billion in 2022 owing to rising cases of zoonotic diseases.

North America animal drugs market is poised to exceed USD 21 billion by 2032 driven by a high pet adoption rate and growing pet care spending in the region.

Elanco Animal Health, Durvet, Inc., Merck & Co., Inc., Neogen Corporation, Inc., Virbac S.A., Vetoquinol SA, Zoetis, Inc. are some of the leading manufacturers of animal drugs worldwide.

Animal Drugs Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 588
  • Countries covered: 21
  • Pages: 344
 Download Free Sample